The list of novel drugs from the post-war era speaks for itself. The contraceptive pill, introduced in 1960, had an impact on society almost as massive as that of penicillin, enabling women to ...

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life ...

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

With increasing pharmaceutical production and a growing focus on patient safety, the demand for specialized and customizable ...

The global pharmaceutical industry is growing and offers an attractive opportunity for investors. Well-established pharmaceutical stocks include AbbVie, Eli Lilly, Johnson & Johnson, and Pfizer.

In recent years, the number of major drug recalls within the Pharmaceutical industry has ... At a minimum, the testing must be done with the list of organisms specified in the pharmacopeia.

Chemical stability: Many medications can be sensitive to pH changes. For instance, certain antibiotics and hormones can break down and lose their effectiveness if they’re not kept in the right pH ...

The FDA decision removed their active ingredient, tirzepatide, from its list of drugs experiencing shortages. That would have cut off access for many patients to the compounded versions they ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TAIPEI, Taiwan, Oct. 25, 2024 /PRNewswire/ -- Bora Pharmaceuticals Co., Ltd. ("Bora" or "the Company", TWSE: 6472), today announced that its Board of Directors has approved the acquisition of US ...

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug Vandana Singh Thu, Oct 17, 2024, 11:07 AM 2 min read ...

LONDON — The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals, which is developing treatments for neurological diseases, in a deal worth $2.6 billion.